查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1864366

電穿孔設備市場按產品類型、應用、最終用戶、技術類型和細胞類型分類－2025-2032年全球預測

Electroporation Instrument Market by Product Type, Application, End User, Technology Type, Cell Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，電穿孔設備市場將成長至 4.3772 億美元，複合年成長率為 5.69%。

主要市場統計數據
基準年 2024 2.81億美元
預計年份：2025年 2.9689億美元
預測年份：2032年 4.3772億美元
複合年成長率 (%) 5.69%

現代電穿孔設備簡述：重點關注技術作用、操作重點以及科學研究和臨床使用者不斷變化的需求

電穿孔裝置是現代生命科學的核心工具，能夠控制細胞膜的通透性，進而促進核酸、蛋白質和小分子的導入。這一系列技術涵蓋了核心研究實驗室使用的桌上型系統，以及新興的攜帶式設備，這些設備拓展了其在現場和即時醫療中的應用。過去十年，儀器外形尺寸和耗材設計的不斷改進，使得通量、可重複性和與上下游工作流程的整合成為優先考慮的因素。因此，採購部門和實驗室管理人員越來越關注營運價值，而不僅僅是資本投資成本。

微流體自動化和治療主導的需求如何重塑研究和臨床工作流程中的電穿孔工具整合、耗材和數據策略

由於技術融合、監管日趨成熟以及終端用戶需求的變化，電穿孔技術領域正經歷快速變革。微流體和連續流電穿孔技術的進步提高了通量和一致性，從而改變了實驗室的設計方式以及製造商的產品藍圖。同時，基因編輯和細胞療法的興起推動了對兼具製程控制和可追溯耗材的系統的需求，促使供應商加大對平台標準化和整合能力的投資。這些變化並非孤立發生，而是與實驗室自動化、數位化和以數據為中心的品質保證等更廣泛的趨勢緊密相連。

評估2025年關稅主導的供應鏈調整如何重塑電穿孔生態系中的採購成本結構、組件供應和採購優先事項。

2025年推出的關稅和貿易措施對電穿孔供應鏈產生了顯著的連鎖反應，促使製造商和實驗室採購負責人重新評估籌資策略和成本結構。精密電極、專用比色皿和脈衝控制電子組件等經常交叉運輸的組件，其到岸成本和前置作業時間波動性均增加。這導致原始設備製造商 (OEM) 加快供應商多元化、區域製造投資和雙重採購策略，以保護關鍵生產線。對於學術機構、受託研究機構和商業機構的採購團隊而言，新的貿易環境更加凸顯了供應可視性和合約應急計畫的重要性。

全面的市場區隔分析揭示了產品類型、應用、終端用戶技術和細胞分類如何影響購買行為和研發重點。

電穿孔設備市場結構在多個維度上呈現高度分層：產品、應用、終端用戶、技術和細胞類型，每個維度都會影響購買決策和產品開發優先順序。就產品類型而言，市場分為配件/耗材和設備兩大類。配件/耗材包括比色皿、電極和流動池等關鍵零件，這些零件決定了實驗的可重複性和單次實驗成本。同時，設備平台分為桌上型和攜帶式，桌上型設備根據通量和通訊協定的複雜程度進一步細分為多脈衝系統和單脈衝系統。

美洲、歐洲、中東和非洲以及亞太地區的區域採用模式、監管差異和供應鏈波動都會影響採購和部署。

區域趨勢對實施模式、監管預期和供應鏈架構有顯著影響。在美洲，對先進治療方法和轉化研究的投資推動了對高性能台式系統和檢驗耗材的強勁需求，而大規模生物製藥公司和合約研究網路的存在則促進了夥伴關係的建立和早期技術的應用。這種環境加速了支援臨床級處理並與現有實驗室自動化生態系統良好整合的平台的普及。隨著我們從北美轉向南美，採購預算和基礎設施成熟度的差異將影響實施策略和售後服務模式。

分析決定電穿孔產業領導地位和細分市場機會的競爭定位、創新、夥伴關係和服務模式

電穿孔生態系的競爭格局由現有設備製造商、專業耗材供應商以及專注於連續流技術和微型化設備的新興技術參與企業共同構成。現有企業通常憑藉其廣泛的平台功能、成熟的通訊協定和全球服務網路展開競爭，而新興新興企業則透過創新的脈衝演算法、微流體技術和軟體驅動的製程控制來脫穎而出。設備原始設備製造商 (OEM) 與耗材專家之間的合作日益普遍，從而能夠提供垂直整合的解決方案，降低採購的不確定性並簡化客戶的採購流程。

為製造商和買家提供切實可行的策略舉措，以增強供應鏈韌性、加速差異化，並在電穿孔解決方案中融入持續價值。

產業領導者應優先考慮增強供應鏈韌性、加速產品差異化並提升客戶終身價值。首先，應實現零件和耗材採購多元化，同時建立區域製造地和分銷中心，以降低關稅和物流風險。這既能確保生產的連續性，又能減少因前置作業時間而導致的專案風險。其次，應投資連續流和微流體技術，作為桌上型產品的策略拓展。這些技術能夠滿足商業開發商和高效能研究客戶對吞吐量和一致性的關鍵需求。第三，應將數位化過程監控和檢驗的通訊協定納入產品系列，以記錄符合臨床和監管要求的可重複性和可追溯性。

我們採用透明、多方面的研究途徑，結合專家訪談、文獻綜述、專利分析和情境檢驗，為我們的實務發現和建議提供了支持。

本分析整合了定性和定量研究，採用多階段調查方法，旨在獲得全面的行業洞察和檢驗。主要研究包括對各領域專家的深入訪談，涵蓋儀器工程、耗材製造、學術和臨床機構的採購人員，以及製藥和生物技術公司的高級研發經理。這些訪談為產品、應用和最終用戶需求的主題映射提供了資訊，並提供了有關營運限制（例如法規遵從性和供應鏈依賴性）的背景資訊。

一份簡明扼要、全面全面的分析報告，重點闡述了技術演進、供應鏈韌性和商業策略的融合如何決定電穿孔市場近期的成功。

電穿孔設備及相關耗材處於科學研究創新與治療開發的關鍵交會點。無論產品類型、應用領域或地理為何，能夠展現可重複效能、應對力法規要求且供應可靠的供應商都具有優勢。從連續流系統到整合資料平台的技術轉型正在改變人們的預期，並開闢新的商業化路徑。同時，貿易措施和不斷演變的籌資策略等外部因素正在加速向更具韌性、以服務為導向的經營模式轉型。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 脈衝電場消融電穿孔系統在治療心律不整的應用
  • 開發攜帶式奈米孔電穿孔裝置，用於現場快速檢測病原體。
  • 利用射頻雙極脈衝電穿孔提高大分子質體DNA的轉染效率
  • 透過整合機器學習演算法實現即時電穿孔參數最佳化和品管
  • 推出一種一次性微流體比色皿，旨在最大程度地減少電穿孔實驗中的交叉污染。
  • 利用電穿孔技術擴展植物性因組編輯平台，以培育耐旱作物
  • 引入基於雲端的軟體平台，用於遠端監控和控制電穿孔通訊協定
  • 設備製造商與學術機構進行策略合作，以規範電穿孔工作流程

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：依產品類型分類的電穿孔設備市場

  • 配件和耗材
    • 比色皿
    • 電極
    • 流動池
  • 裝置
    • 桌面型
      • 多重脈衝
      • 單脈衝
    • 手持式

第9章 按應用分類的電穿孔設備市場

  • 學術研究
    • 癌症研究
    • 分子生物學
    • 疫苗研發
  • CRO（受託研究機構）
    • 臨床研究
    • 臨床前研究
  • 藥物生物技術
    • 農業生物技術
    • 細胞療法
    • 基因治療

第10章 按最終用戶分類的電穿孔設備市場

  • 學術和研究機構
  • CRO（受託研究機構）
  • 醫院診所
  • 製藥和生物技術公司

第11章 依技術類型分類的電穿孔設備市場

  • 批次類型
  • 連續流

第12章：按細胞類型分類的電穿孔設備市場

  • 貼壁細胞
    • 昆蟲細胞
    • 哺乳動物貼壁細胞
    • 植物細胞
  • 懸浮細胞
    • 細菌懸浮細胞
    • 哺乳動物懸浮細胞
    • 酵母菌細胞

第13章 電穿孔設備市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 電穿孔設備市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國電穿孔設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Thermo Fisher Scientific Inc.
    • Lonza Group AG
    • Bio-Rad Laboratories, Inc.
    • Merck KGaA
    • Eppendorf AG
    • Harvard Bioscience, Inc.
    • MaxCyte, Inc.
    • BEX Co., Ltd.
    • Nepa Gene Co., Ltd.
    • CytoPulse Sciences, Inc.
Product Code: MRR-E1122A48A8B0

The Electroporation Instrument Market is projected to grow by USD 437.72 million at a CAGR of 5.69% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 281.00 million
Estimated Year [2025] USD 296.89 million
Forecast Year [2032] USD 437.72 million
CAGR (%) 5.69%

A concise orientation to contemporary electroporation instruments highlighting technological roles operational priorities and the evolving expectations of research and clinical users

Electroporation instruments are central tools in contemporary life sciences, enabling the controlled permeabilization of cellular membranes to facilitate the delivery of nucleic acids, proteins, and small molecules. This suite of technologies spans bench-top systems used in core research laboratories to emerging handheld devices that expand in-field and point-of-care applications. Over the past decade, the evolution of instrument form factors and consumable design has shifted priorities toward throughput, reproducibility, and integration with upstream and downstream workflows. Consequently, procurement teams and laboratory directors increasingly emphasize total operational value rather than capital cost alone.

Moreover, electroporation has moved beyond a niche laboratory technique to a foundational enabler for advanced therapies and complex molecular biology workflows. Clinical-grade delivery for cell and gene therapies demands rigorous process control, traceable consumables, and validated protocols, while academic and translational research groups prioritize flexibility and rapid prototyping. As a result, manufacturers are balancing the need for regulatory-compliant platforms with modular architectures that support diverse research applications. Transitioning from basic technique to platform-level thinking, stakeholders must now weigh instrument interoperability, consumable lifecycle management, and services that reduce time-to-data for high-stakes programs.

How microfluidics automation and therapy-driven requirements are reshaping electroporation tools integration consumables and data strategies across research and clinical workflows

The electroporation landscape is undergoing rapid transformation driven by technological convergence, regulatory maturation, and changing end-user expectations. Advances in microfluidics and continuous-flow electroporation technologies are enabling higher throughput and greater consistency, which, in turn, are reshaping how laboratories design experiments and how manufacturers structure product roadmaps. At the same time, the rise of gene editing and cell therapies has increased demand for systems that combine process control with traceable consumables, prompting suppliers to invest in platform-standardization and integration capabilities. These shifts are not occurring in isolation; rather, they are linked to broader trends in laboratory automation, digitalization, and data-centric quality assurance.

In parallel, miniaturization and portability have expanded use-cases for handheld and benchtop instruments, enabling decentralized workflows and point-of-care research settings. Integration with laboratory information management systems and data analytics tools is becoming a differentiator, as customers seek reproducible protocols and real-time process monitoring. Notably, consumables design is also evolving: disposability for contamination control, precision-engineered cuvettes and electrodes for reduced variability, and flow cell geometries optimized for specific cell types are becoming market requirements. As a result, competitive advantage increasingly depends on the ability to offer holistic solutions that combine hardware, consumables, software, and service.

Assessing the 2025 tariff-driven supply chain adjustments that have reshaped sourcing cost structures component availability and procurement priorities in electroporation ecosystems

The introduction of tariffs and trade measures in 2025 has created material ripple effects across the electroporation supply chain, prompting manufacturers and laboratory buyers to reassess sourcing strategies and cost structures. Components that are frequently cross-shipped-such as precision electrodes, specialized cuvettes, and electronic assemblies for pulse control-have experienced increased landed costs and lead-time volatility. Consequently, original equipment manufacturers have accelerated supplier diversification, regional manufacturing investments, and dual-sourcing strategies to protect critical production lines. For procurement teams in academic, contract research, and commercial settings, the new trade environment has reinforced the importance of supply visibility and contract contingencies.

Furthermore, tariffs have magnified the relative cost impact of consumables in high-frequency usage contexts, incentivizing laboratories to evaluate consumable efficiency and compatibility across platforms. In response, several suppliers have emphasized local stocking agreements and expanded aftermarket services to reduce the operational risks associated with cross-border delays. For multinational purchasers, tariff-induced pricing pressure has prompted negotiations around bundled service contracts, extended warranties, and volume-based commitments. Ultimately, the cumulative effect is a shift toward supply chain resilience and service-oriented commercial models, which moderate the immediate price shock while aligning supplier incentives with customer continuity and regulatory compliance.

Comprehensive segmentation review clarifying how product types applications end users technologies and cell classifications drive purchasing behavior and R&D priorities

The market architecture for electroporation instruments is richly stratified across product, application, end-user, technology, and cell-type dimensions, each of which informs purchasing decisions and product development priorities. From the perspective of product type, the landscape is split between accessories and consumables and instruments. Accessories and consumables include requisite items such as cuvettes, electrodes, and flow cells that determine repeatability and per-experiment economics, while instrument platforms differentiate into bench-top and handheld solutions, with bench-top devices further subdivided into multi-pulse and single-pulse systems that align with throughput and protocol complexity.

Application-focused segmentation highlights distinct workflow requirements: academic research encompasses domains like cancer research, molecular biology, and vaccine development where flexibility and method development are key; contract research organizations operate across clinical and preclinical research and therefore prioritize validated processes, scalability, and documentation; pharmaceutical and biotechnology users address areas such as agricultural biotechnology, cell therapy, and gene therapy where regulatory rigor and process transferability dominate procurement decisions. End-user categories reflect the purchasing contexts of academic and research institutions, contract research organizations, hospitals and clinics, and pharmaceutical and biotechnology companies, each presenting unique service expectations and compliance profiles.

Technology-type considerations bifurcate into batch and continuous flow approaches, with continuous flow gaining traction where homogeneity and high throughput are essential. Cell-type segmentation further refines instrument and consumable requirements: adherent cells, including insect, mammalian adherent, and plant cells, impose constraints on handling and electroporation parameters, while suspension cells-comprising bacterial suspension, mammalian suspension, and yeast cells-demand alternate delivery geometries and flow dynamics. Collectively, these segmentation layers influence product roadmaps, go-to-market tactics, and aftersales offerings, and they underscore the need for manufacturers to align platform capabilities with the nuanced demands of each customer cohort.

Regional adoption patterns regulatory nuances and supply chain variations across the Americas Europe Middle East Africa and Asia-Pacific that influence procurement and deployment

Regional dynamics exert a pronounced influence on adoption patterns, regulatory expectations, and supply chain architecture. In the Americas, investment in advanced therapies and translational research has driven strong demand for high-capability bench-top systems and validated consumables, while the presence of large biopharma and contract research networks fosters partnerships and early technology adoption. This environment accelerates the uptake of platforms that support clinical-grade processing and integrates well with established laboratory automation ecosystems. Moving from North to South within the region, variations in procurement budgets and infrastructure maturity shape deployment strategies and aftermarket service models.

Across Europe, Middle East & Africa, stakeholders contend with a diverse regulatory environment and a mix of established research institutions and emerging biotech clusters. European centers of excellence emphasize reproducibility, regulatory compliance, and interoperability with certified laboratory equipment, prompting suppliers to prioritize robust documentation and localized technical support. In parts of the Middle East and Africa, pioneering investments in life sciences and agricultural biotech are creating nascent markets for portable and cost-efficient instruments, while regional partnerships often focus on knowledge transfer and capacity building.

The Asia-Pacific region displays rapid commercial expansion driven by growing biotechnology sectors, high-throughput manufacturing facilities, and a large base of research institutions. Local manufacturing capabilities and government-backed innovation programs have encouraged the development of domestic suppliers and hybrid sourcing strategies. Meanwhile, end users across the region show a strong appetite for continuous-flow solutions and scalable platforms that can serve both research and commercial production workflows. Taken together, these regional dynamics call for nuanced market entry strategies, differentiated service footprints, and localized product adaptations.

An analysis of competitive positioning innovation partnerships and service models that determine leadership and niche opportunity capture within the electroporation industry

Competitive dynamics in the electroporation ecosystem are shaped by a combination of legacy instrument manufacturers, specialized consumable providers, and emerging technology entrants focused on continuous flow and miniaturized devices. Established players typically compete on the breadth of platform capabilities, proven protocols, and global service networks, while newer companies differentiate through novel pulse algorithms, microfluidic innovations, and software-enabled process control. Alliances between instrument OEMs and consumable specialists have become increasingly common, enabling vertically integrated solutions that reduce variability and simplify customer procurement.

Strategic activity has also concentrated on after-sales services, consumable capture models, and partnerships with clinical and academic centers to validate new applications. Companies that secure preferred supplier status within large research networks benefit from recurring consumable revenue streams and early access to protocol adaptations. Patent portfolios around pulse-shaping technologies, electrode materials, and flow-cell architectures contribute to competitive moats, and firms with modular platforms can accelerate adoption by offering upgrade paths rather than full replacements. Looking ahead, organizations that combine rigorous regulatory support with flexible commercial options and strong technical service capabilities will maintain leadership positions while new entrants seize niche opportunities through focused innovation.

Practical strategic initiatives for manufacturers and purchasers to strengthen supply resilience accelerate differentiation and embed recurring value across electroporation solutions

Industry leaders should prioritize strategies that reinforce supply resilience, accelerate product differentiation, and enhance customer lifetime value. First, diversify component and consumable sourcing while establishing regional manufacturing or distribution hubs to mitigate tariff and logistics exposure; this will preserve production continuity and reduce lead-time-driven program risk. Second, invest in continuous-flow and microfluidic capabilities as strategic extensions of bench-top offerings, because these technologies address throughput and consistency requirements that matter to both commercial developers and high-throughput research customers. Third, embed digital process monitoring and validated protocols into product portfolios to deliver reproducibility and traceability that align with clinical and regulatory expectations.

In addition, cultivate deeper partnerships with contract research organizations, hospitals, and large academic centers to co-develop workflows and secure early validation of new consumables and pulse regimes. Consider bundled commercial models that combine hardware, consumables, software, and service to provide predictable total cost of ownership and to lock in recurring revenue. Finally, prioritize a modular platform strategy that enables incremental upgrades and aftermarket monetization, while investing in customer education and technical support programs that reduce barriers to adoption and accelerate technology transfer from the laboratory to clinical or commercial environments.

A transparent multi-method research approach integrating expert interviews literature review patent analysis and scenario validation to underpin actionable insights and recommendations

This analysis synthesizes qualitative and quantitative research conducted through a multi-step methodology designed to achieve comprehensive sector insight and validation. Primary research included in-depth interviews with subject-matter experts spanning instrument engineering, consumables manufacturing, procurement leads within academic and clinical institutions, and senior R&D managers in pharmaceutical and biotechnology firms. These interviews informed thematic mapping of product, application, and end-user requirements, and they provided context for operational constraints such as regulatory compliance and supply chain dependencies.

Secondary research comprised an exhaustive review of technical literature, regulatory guidance, patent filings, company disclosures, and trade publications to triangulate technological trends and competitive activity. Data were further validated through cross-referencing of procurement procedures, public tender records, and reported collaboration announcements to ensure that observed trends reflected operational realities. Analytical techniques included segmentation mapping, scenario analysis for supply chain disruptions, and qualitative benchmarking of service propositions. Finally, findings were peer-reviewed by an internal expert panel and refined to ensure that conclusions are actionable for decision-makers in procurement, R&D, and corporate strategy roles.

A concise synthesis highlighting the convergence of technological evolution supply resilience and commercial strategies that will determine near-term success in electroporation markets

Electroporation instruments and their associated consumables now occupy a strategic intersection between research innovation and therapeutic development. Across product types, applications, and regions, the landscape favors suppliers that can demonstrate reproducible performance, regulatory readiness, and supply reliability. Transformations in technology-from continuous-flow systems to integrated data platforms-are altering expectations and creating new pathways for commercialization. At the same time, external forces such as trade measures and evolving procurement strategies are accelerating the shift toward resilient, service-oriented business models.

For stakeholders, the imperative is clear: align platform development with real-world workflow needs, invest in consumable standardization and validation, and pursue commercial models that prioritize long-term partnerships over transactional sales. By doing so, organizations can reduce operational friction, support faster translational timelines, and capture value across the instrument lifecycle. In sum, the immediate window of opportunity favors those who combine technical excellence with pragmatic supply and commercial strategies to support the next generation of research and therapeutic programs.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of pulsed field ablation electroporation systems in cardiac arrhythmia therapy
  • 5.2. Development of handheld nanopore-enabled electroporation devices for rapid on-site pathogen detection
  • 5.3. Use of high-frequency bipolar pulse electroporation to enhance large plasmid DNA transfection efficiency
  • 5.4. Integration of machine learning algorithms for real-time electroporation parameter optimization and quality control
  • 5.5. Emergence of disposable microfluidic cuvettes designed to minimize cross-contamination in electroporation assays
  • 5.6. Expansion of electroporation-based plant genome editing platforms for drought-resistant crop development
  • 5.7. Implementation of cloud-connected software platforms for remote monitoring and controlling electroporation protocols
  • 5.8. Strategic partnerships between device manufacturers and academic institutions to standardize electroporation workflows

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Electroporation Instrument Market, by Product Type

  • 8.1. Accessories & Consumables
    • 8.1.1. Cuvettes
    • 8.1.2. Electrodes
    • 8.1.3. Flow Cells
  • 8.2. Instruments
    • 8.2.1. Bench-Top
      • 8.2.1.1. Multi Pulse
      • 8.2.1.2. Single Pulse
    • 8.2.2. Handheld

9. Electroporation Instrument Market, by Application

  • 9.1. Academic Research
    • 9.1.1. Cancer Research
    • 9.1.2. Molecular Biology
    • 9.1.3. Vaccine Development
  • 9.2. Contract Research Organizations
    • 9.2.1. Clinical Research
    • 9.2.2. Preclinical Research
  • 9.3. Pharmaceutical & Biotechnology
    • 9.3.1. Agricultural Biotechnology
    • 9.3.2. Cell Therapy
    • 9.3.3. Gene Therapy

10. Electroporation Instrument Market, by End User

  • 10.1. Academic & Research Institutions
  • 10.2. Contract Research Organizations
  • 10.3. Hospitals & Clinics
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Electroporation Instrument Market, by Technology Type

  • 11.1. Batch
  • 11.2. Continuous Flow

12. Electroporation Instrument Market, by Cell Type

  • 12.1. Adherent Cells
    • 12.1.1. Insect Cells
    • 12.1.2. Mammalian Adherent Cells
    • 12.1.3. Plant Cells
  • 12.2. Suspension Cells
    • 12.2.1. Bacterial Suspension Cells
    • 12.2.2. Mammalian Suspension Cells
    • 12.2.3. Yeast Cells

13. Electroporation Instrument Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Electroporation Instrument Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Electroporation Instrument Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Thermo Fisher Scientific Inc.
    • 16.3.2. Lonza Group AG
    • 16.3.3. Bio-Rad Laboratories, Inc.
    • 16.3.4. Merck KGaA
    • 16.3.5. Eppendorf AG
    • 16.3.6. Harvard Bioscience, Inc.
    • 16.3.7. MaxCyte, Inc.
    • 16.3.8. BEX Co., Ltd.
    • 16.3.9. Nepa Gene Co., Ltd.
    • 16.3.10. CytoPulse Sciences, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ELECTROPORATION INSTRUMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ELECTROPORATION INSTRUMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ELECTROPORATION INSTRUMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CUVETTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CUVETTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CUVETTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CUVETTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CUVETTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CUVETTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ELECTRODES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ELECTRODES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ELECTRODES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ELECTRODES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ELECTRODES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ELECTRODES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY FLOW CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY FLOW CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY FLOW CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY FLOW CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY FLOW CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY FLOW CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MULTI PULSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MULTI PULSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MULTI PULSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MULTI PULSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MULTI PULSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MULTI PULSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SINGLE PULSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SINGLE PULSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SINGLE PULSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SINGLE PULSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SINGLE PULSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SINGLE PULSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HANDHELD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HANDHELD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HANDHELD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HANDHELD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HANDHELD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HANDHELD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CANCER RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CANCER RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CANCER RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CANCER RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MOLECULAR BIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MOLECULAR BIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MOLECULAR BIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MOLECULAR BIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MOLECULAR BIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MOLECULAR BIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY VACCINE DEVELOPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY VACCINE DEVELOPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY VACCINE DEVELOPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY VACCINE DEVELOPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CLINICAL RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CLINICAL RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CLINICAL RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CLINICAL RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY GENE THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY GENE THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTINUOUS FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTINUOUS FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTINUOUS FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTINUOUS FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSECT CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSECT CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSECT CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSECT CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSECT CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSECT CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN ADHERENT CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN ADHERENT CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN ADHERENT CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN ADHERENT CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN ADHERENT CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN ADHERENT CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PLANT CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PLANT CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PLANT CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PLANT CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PLANT CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PLANT CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BACTERIAL SUSPENSION CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BACTERIAL SUSPENSION CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BACTERIAL SUSPENSION CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BACTERIAL SUSPENSION CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BACTERIAL SUSPENSION CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BACTERIAL SUSPENSION CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN SUSPENSION CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN SUSPENSION CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN SUSPENSION CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN SUSPENSION CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN SUSPENSION CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY MAMMALIAN SUSPENSION CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY YEAST CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY YEAST CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY YEAST CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY YEAST CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY YEAST CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY YEAST CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 270. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY BENCH-TOP, 2025-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 278. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY ADHERENT CELLS, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY SUSPENSION CELLS, 2025-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. LATIN AMERICA E